United States Biotechnology & Medical Research

Arcellx Inc (ACLX)

Track

The most recent insider trading activity occurred on February 27, 2026. Significant sell transactions were reported by Rami Elghandour and Michelle Gilson. These transactions involved substantial share values, indicating notable divestments by key executives. The overall pattern suggests a period of selling by insiders.

Not featured in screeners

Featured in screeners

Not featured in screeners

Stock chart

Ticker: ACLX Exchange: NSM

Subscribe to get access to the transaction volume chart and in-chart transaction details

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings

Top insiders

Company data & Insiders

Subscribe to get access to the company description and key fundamental data (market cap, shares outstanding, dividend yield, % of shares held by insiders and more)

Download results Settings

Trades

Elghandour Rami

SEE REMARKS

2 sales — total 20,486,534 USD

Sale 27 Feb 2026

Value US$3,406,281.55 | Price 402.69 | Shares 86,542

Proposed sale 27 Feb 2026

Value US$2,306,657.34 | Price 233.69 | Shares 47,392

Gilson Michelle

CHIEF FINANCIAL OFFICER

2 sales — total 2,553,909 USD

Sale 25 Feb 2026

Value US$3,626,317.32 | Price 382.55 | Shares 79,955

Proposed sale 25 Feb 2026

Value US$3,301,269.93 | Price 329.33 | Shares 7,002

Gilson Michelle

Officer

4 sales — total 1,145,136 USD

Proposed sale 19 Feb 2026

Value US$572,567.73 | Price 68.29 | Shares 8,384

Sale 19 Feb 2026

Value US$6,938.00 | Price 69.38 | Shares 100

Sale 19 Feb 2026

Value US$370,634.90 | Price 68.57 | Shares 5,405

Sale 19 Feb 2026

Value US$194,994.96 | Price 67.73 | Shares 2,879

Gilson Michelle

CHIEF FINANCIAL OFFICER

3 sales — total 1,569,565 USD

Sale 17 Feb 2026

Value US$290,551.88 | Price 70.01 | Shares 4,150

Sale 17 Feb 2026

Value US$494,230.75 | Price 69.21 | Shares 7,141

Proposed sale 17 Feb 2026

Value US$784,782.47 | Price 69.51 | Shares 11,291

DAVID LUBNER

Director

1 sale — total 1,034,100 USD

Proposed sale 20 Jan 2026

Value US$1,034,100.00 | Price 68.94 | Shares 15,000

Lubner David Charles

1 sale — total 450,000 USD

Planned sale 20 Jan 2026

Value US$450,000.00 | Price 75.00 | Shares 6,000

Heery Christopher

Officer

2 sales — total 805,994 USD

Proposed sale 14 Jan 2026

Value US$402,997.10 | Price 68.51 | Shares 5,882

Sale 14 Jan 2026

Value US$402,997.00 | Price 68.51 | Shares 5,882

Heery Christopher

Officer

2 sales — total 974,426 USD

Proposed sale 13 Jan 2026

Value US$487,213.08 | Price 65.51 | Shares 7,437

Sale 13 Jan 2026

Value US$487,212.74 | Price 65.51 | Shares 7,437

Heery Christopher

Officer

2 sales — total 786,572 USD

Proposed sale 12 Jan 2026

Value US$393,286.14 | Price 64.15 | Shares 6,131

Sale 12 Jan 2026

Value US$393,285.87 | Price 64.15 | Shares 6,131

Heery Christopher

CHIEF MEDICAL OFFICER

1 sale — total 30,600 USD

Planned sale 17 Nov 2025

Value US$30,600.00 | Price 90.00 | Shares 340

MICHELLE GILSON

Officer

1 sale — total 468,438 USD

Proposed sale 15 Oct 2025

Value US$468,438.12 | Price 87.33 | Shares 5,364

Gilson Michelle

CHIEF FINANCIAL OFFICER

1 sale — total 488,315 USD

Planned sale 15 Oct 2025

Value US$488,315.49 | Price 91.04 | Shares 5,364

Gilson Michelle

CHIEF FINANCIAL OFFICER

1 sale — total 91,733 USD

Planned sale 6 Oct 2025

Value US$91,733.29 | Price 86.22 | Shares 1,064

Gilson Michelle

CHIEF FINANCIAL OFFICER

1 sale — total 419,870 USD

Planned sale 3 Oct 2025

Value US$419,869.58 | Price 86.00 | Shares 4,882

MICHELLE GILSON

Officer

1 sale — total 488,999 USD

Proposed sale 3 Oct 2025

Value US$488,999.04 | Price 82.24 | Shares 5,946

Heery Christopher

CHIEF MEDICAL OFFICER

3 sales — total 1,709,723 USD

Planned sale 30 Sep 2025

Value US$125,762.94 | Price 82.20 | Shares 1,530

Planned sale 30 Sep 2025

Value US$1,157,035.11 | Price 81.46 | Shares 14,204

Planned sale 30 Sep 2025

Value US$426,924.54 | Price 80.55 | Shares 5,300

Heery Christopher

CHIEF MEDICAL OFFICER

1 sale — total 5,852 USD

Planned sale 29 Sep 2025

Value US$5,851.68 | Price 80.16 | Shares 73

Heery Christopher

CHIEF MEDICAL OFFICER

1 sale — total 993,155 USD

Planned sale 26 Sep 2025

Value US$993,155.12 | Price 80.12 | Shares 12,396

Heery Christopher

CHIEF MEDICAL OFFICER

1 sale — total 24,000 USD

Planned sale 19 Sep 2025

Value US$24,000.00 | Price 80.00 | Shares 300

Heery Christopher

CHIEF MEDICAL OFFICER

1 sale — total 267,468 USD

Planned sale 18 Sep 2025

Value US$267,468.42 | Price 80.01 | Shares 3,343

CHRISTOPHER HEERY

Officer

1 sale — total 2,864,680 USD

Proposed sale 18 Sep 2025

Value US$2,864,680.12 | Price 76.42 | Shares 37,486

Patel Kavita

1 sale — total 101,040 USD

Planned sale 10 Jun 2025

Value US$101,040.00 | Price 67.36 | Shares 1,500

KAVITA K PATEL

Director

1 sale — total 100,290 USD

Proposed sale 10 Jun 2025

Value US$100,290.00 | Price 66.86 | Shares 1,500

Gilson Michelle

CHIEF FINANCIAL OFFICER

3 sales — total 1,569,553 USD

Sale 27 May 2025

Value US$543,908.60 | Price 64.38 | Shares 8,449

Sale 27 May 2025

Value US$240,867.97 | Price 63.62 | Shares 3,786

Proposed sale 27 May 2025

Value US$784,776.20 | Price 64.14 | Shares 12,235

Patel Kavita

1 sale — total 87,645 USD

Planned sale 20 May 2025

Value US$87,645.00 | Price 58.43 | Shares 1,500

Yoon Derek

Director

1 sale — total 1,207,529 USD

Proposed sale 29 Apr 2025

Value US$1,207,529.40 | Price 62.02 | Shares 19,470

Patel Kavita

1 sale — total 96,300 USD

Planned sale 29 Apr 2025

Value US$96,300.00 | Price 64.20 | Shares 1,500

Patel Kavita

1 sale — total 86,250 USD

Planned sale 8 Apr 2025

Value US$86,250.00 | Price 57.50 | Shares 1,500

Patel Kavita

1 sale — total 107,460 USD

Planned sale 18 Mar 2025

Value US$107,460.00 | Price 71.64 | Shares 1,500

Elghandour Rami

Officer; Director

4 sales — total 4,751,034 USD

Proposed sale 26 Feb 2025

Value US$2,375,516.95 | Price 62.02 | Shares 38,300

Sale 26 Feb 2025

Value US$682,624.88 | Price 62.69 | Shares 10,889

Sale 26 Feb 2025

Value US$1,305,644.27 | Price 61.95 | Shares 21,077

Sale 26 Feb 2025

Value US$387,248.09 | Price 61.14 | Shares 6,334

KAVITA K PATEL

Director

1 sale — total 472,575 USD

Proposed sale 25 Feb 2025

Value US$472,575.00 | Price 63.01 | Shares 7,500

Patel Kavita

1 sale — total 94,740 USD

Planned sale 25 Feb 2025

Value US$94,740.00 | Price 63.16 | Shares 1,500

Heery Christopher

Officer

4 sales — total 1,295,545 USD

Proposed sale 24 Feb 2025

Value US$647,772.86 | Price 63.79 | Shares 10,155

Sale 24 Feb 2025

Value US$13,494.58 | Price 64.88 | Shares 208

Sale 24 Feb 2025

Value US$358,360.17 | Price 64.26 | Shares 5,577

Sale 24 Feb 2025

Value US$275,917.87 | Price 63.14 | Shares 4,370

Patel Kavita

1 sale — total 96,855 USD

Planned sale 4 Feb 2025

Value US$96,855.00 | Price 64.57 | Shares 1,500

Patel Kavita

3 sales — total 98,801 USD

Planned sale 14 Jan 2025

Value US$20,195.01 | Price 67.32 | Shares 300

Planned sale 14 Jan 2025

Value US$26,649.00 | Price 66.62 | Shares 400

Planned sale 14 Jan 2025

Value US$51,957.20 | Price 64.95 | Shares 800

Elghandour Rami

SEE REMARKS

1 sale — total 1,019,689 USD

Sale 8 Jan 2025

Value US$1,019,688.66 | Price 73.69 | Shares 13,837

Gilson Michelle

CHIEF FINANCIAL OFFICER

1 sale — total 294,551 USD

Sale 8 Jan 2025

Value US$294,550.52 | Price 73.69 | Shares 3,997

Heery Christopher

CHIEF MEDICAL OFFICER

1 sale — total 261,831 USD

Sale 8 Jan 2025

Value US$261,830.87 | Price 73.69 | Shares 3,553

Elghandour Rami

SEE REMARKS

2 sales — total 3,661,159 USD

Sale 7 Jan 2025

Value US$1,244,253.21 | Price 75.53 | Shares 16,474

Proposed sale 7 Jan 2025

Value US$2,416,905.60 | Price 75.53 | Shares 32,000

Gilson Michelle

CHIEF FINANCIAL OFFICER

6 sales — total 1,747,781 USD

Sale 7 Jan 2025

Value US$359,514.71 | Price 75.53 | Shares 4,760

Planned sale 7 Jan 2025

Value US$179,319.78 | Price 77.06 | Shares 2,327

Planned sale 7 Jan 2025

Value US$172,521.59 | Price 76.64 | Shares 2,251

Planned sale 7 Jan 2025

Value US$116,310.68 | Price 75.23 | Shares 1,546

Planned sale 7 Jan 2025

Value US$232,807.03 | Price 74.43 | Shares 3,128

Proposed sale 7 Jan 2025

Value US$687,307.53 | Price 75.53 | Shares 9,100

Heery Christopher

CHIEF MEDICAL OFFICER

2 sales — total 931,264 USD

Sale 7 Jan 2025

Value US$319,484.71 | Price 75.53 | Shares 4,230

Proposed sale 7 Jan 2025

Value US$611,779.23 | Price 75.53 | Shares 8,100

MICHELLE GILSON

Officer

1 sale — total 693,993 USD

Proposed sale 7 Jan 2025

Value US$693,992.52 | Price 75.01 | Shares 9,252

Gilson Michelle

CHIEF FINANCIAL OFFICER

1 sale — total 393,705 USD

Sale 6 Jan 2025

Value US$393,705.01 | Price 77.17 | Shares 5,102

Heery Christopher

CHIEF MEDICAL OFFICER

2 sales — total 472,415 USD

Sale 6 Jan 2025

Value US$236,207.57 | Price 77.17 | Shares 3,061

Sale 6 Jan 2025

Value US$236,207.57 | Price 77.17 | Shares 3,061

Elghandour Rami

SEE REMARKS

1 sale — total 1,063,050 USD

Sale 6 Jan 2025

Value US$1,063,049.84 | Price 77.17 | Shares 13,776

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Value
2026-02-27	2026-02-27	S Sale	3.3 Elghandour Rami SEE REMARKS Executive Director	86,542 -24.7% 402.69 US$3,406,282	86,542 -24.7%	402.69	US$3,406,282
2026-02-27	2026-02-27	PrS Proposed sale	3.3 Elghandour Rami Officer; Director Executive Director	47,392 233.69 US$2,306,657	47,392	233.69	US$2,306,657
2026-02-25	2026-02-25	S Sale	2.8 Gilson Michelle CHIEF FINANCIAL OFFICER Officer	79,955 -21.5% 382.55 US$3,626,317	79,955 -21.5%	382.55	US$3,626,317
2026-02-25	2026-02-25	PrS Proposed sale	2.8 Gilson Michelle Officer Officer	11,219 113.82 US$1,276,955	11,219	113.82	US$1,276,955
2026-02-19	2026-02-19	PrS Proposed sale	2.8 Gilson Michelle Officer Officer	8,384 68.29 US$572,568	8,384	68.29	US$572,568
2026-02-19	2026-02-19	S Sale	2.8 Gilson Michelle CHIEF FINANCIAL OFFICER Officer	100 -0.2% 69.38 US$6,938	100 -0.2%	69.38	US$6,938
2026-02-19	2026-02-19	S Sale	2.8 Gilson Michelle CHIEF FINANCIAL OFFICER Officer	5,405 -10.7% 68.57 US$370,635	5,405 -10.7%	68.57	US$370,635
2026-02-19	2026-02-19	S Sale	2.8 Gilson Michelle CHIEF FINANCIAL OFFICER Officer	2,879 -5.4% 67.73 US$194,995	2,879 -5.4%	67.73	US$194,995
2026-02-18	2026-02-17	S Sale	2.8 Gilson Michelle CHIEF FINANCIAL OFFICER Officer	4,150 -7.2% 70.01 US$290,552	4,150 -7.2%	70.01	US$290,552
2026-02-18	2026-02-17	S Sale	2.8 Gilson Michelle CHIEF FINANCIAL OFFICER Officer	7,141 -11.0% 69.21 US$494,231	7,141 -11.0%	69.21	US$494,231
2026-02-17	2026-02-17	PrS Proposed sale	2.8 Gilson Michelle Officer Officer	11,291 69.51 US$784,782	11,291	69.51	US$784,782
2026-01-20	2026-01-20	PrS Proposed sale	2.2 DAVID LUBNER Director Non-Executive Director	15,000 68.94 US$1,034,100	15,000	68.94	US$1,034,100
2026-01-20	2026-01-20	PlS Planned sale	2.2 Lubner David Charles Non-Executive Director	6,000 -21.7% 75.00 US$450,000	6,000 -21.7%	75.00	US$450,000
2026-01-14	2026-01-14	PrS Proposed sale	2.3 Heery Christopher Officer Officer	5,882 68.51 US$402,997	5,882	68.51	US$402,997
2026-01-14	2026-01-14	S Sale	2.3 Heery Christopher CHIEF MEDICAL OFFICER Officer	5,882 -19.9% 68.51 US$402,997	5,882 -19.9%	68.51	US$402,997
2026-01-13	2026-01-13	PrS Proposed sale	2.3 Heery Christopher Officer Officer	7,437 65.51 US$487,213	7,437	65.51	US$487,213
2026-01-13	2026-01-13	S Sale	2.3 Heery Christopher CHIEF MEDICAL OFFICER Officer	7,437 -20.1% 65.51 US$487,213	7,437 -20.1%	65.51	US$487,213
2026-01-12	2026-01-12	PrS Proposed sale	2.3 Heery Christopher Officer Officer	6,131 64.15 US$393,286	6,131	64.15	US$393,286
2026-01-12	2026-01-12	S Sale	2.3 Heery Christopher CHIEF MEDICAL OFFICER Officer	6,131 -14.2% 64.15 US$393,286	6,131 -14.2%	64.15	US$393,286
2025-11-17	2025-11-17	PlS Planned sale	2.3 Heery Christopher CHIEF MEDICAL OFFICER Officer	340 -54.5% 90.00 US$30,600	340 -54.5%	90.00	US$30,600
2025-10-15	2025-10-15	PrS Proposed sale	2.8 MICHELLE GILSON Officer Officer	5,364 87.33 US$468,438	5,364	87.33	US$468,438
2025-10-15	2025-10-15	PlS Planned sale	2.8 Gilson Michelle CHIEF FINANCIAL OFFICER Officer	5,364 -38.8% 91.04 US$488,315	5,364 -38.8%	91.04	US$488,315
2025-10-06	2025-10-06	PlS Planned sale	2.8 Gilson Michelle CHIEF FINANCIAL OFFICER Officer	1,064 -7.1% 86.22 US$91,733	1,064 -7.1%	86.22	US$91,733
2025-10-06	2025-10-03	PlS Planned sale	2.8 Gilson Michelle CHIEF FINANCIAL OFFICER Officer	4,882 -24.7% 86.00 US$419,870	4,882 -24.7%	86.00	US$419,870
2025-10-03	2025-10-03	PrS Proposed sale	2.8 MICHELLE GILSON Officer Officer	5,946 82.24 US$488,999	5,946	82.24	US$488,999
2025-09-30	2025-09-30	PlS Planned sale	2.3 Heery Christopher CHIEF MEDICAL OFFICER Officer	1,530 -71.0% 82.20 US$125,763	1,530 -71.0%	82.20	US$125,763
2025-09-30	2025-09-30	PlS Planned sale	2.3 Heery Christopher CHIEF MEDICAL OFFICER Officer	14,204 -86.8% 81.46 US$1,157,035	14,204 -86.8%	81.46	US$1,157,035
2025-09-30	2025-09-30	PlS Planned sale	2.3 Heery Christopher CHIEF MEDICAL OFFICER Officer	5,300 -24.5% 80.55 US$426,925	5,300 -24.5%	80.55	US$426,925
2025-09-29	2025-09-29	PlS Planned sale	2.3 Heery Christopher CHIEF MEDICAL OFFICER Officer	73 -0.3% 80.16 US$5,852	73 -0.3%	80.16	US$5,852
2025-09-26	2025-09-26	PlS Planned sale	2.3 Heery Christopher CHIEF MEDICAL OFFICER Officer	12,396 -36.3% 80.12 US$993,155	12,396 -36.3%	80.12	US$993,155
2025-09-19	2025-09-19	PlS Planned sale	2.3 Heery Christopher CHIEF MEDICAL OFFICER Officer	300 -0.9% 80.00 US$24,000	300 -0.9%	80.00	US$24,000
2025-09-19	2025-09-18	PlS Planned sale	2.3 Heery Christopher CHIEF MEDICAL OFFICER Officer	3,343 -8.9% 80.01 US$267,468	3,343 -8.9%	80.01	US$267,468
2025-09-18	2025-09-18	PrS Proposed sale	2.3 CHRISTOPHER HEERY Officer Officer	37,486 76.42 US$2,864,680	37,486	76.42	US$2,864,680
2025-06-11	2025-06-10	PlS Planned sale	Patel Kavita Non-Executive Director	1,500 -100.0% 67.36 US$101,040	1,500 -100.0%	67.36	US$101,040
2025-06-10	2025-06-10	PrS Proposed sale	KAVITA K PATEL Director Non-Executive Director	1,500 66.86 US$100,290	1,500	66.86	US$100,290
2025-05-28	2025-05-27	S Sale	2.8 Gilson Michelle CHIEF FINANCIAL OFFICER Officer	8,449 -29.9% 64.38 US$543,909	8,449 -29.9%	64.38	US$543,909
2025-05-28	2025-05-27	S Sale	2.8 Gilson Michelle CHIEF FINANCIAL OFFICER Officer	3,786 -11.8% 63.62 US$240,868	3,786 -11.8%	63.62	US$240,868
2025-05-27	2025-05-27	PrS Proposed sale	2.8 Gilson Michelle Officer Officer	12,235 64.14 US$784,776	12,235	64.14	US$784,776
2025-05-20	2025-05-20	PlS Planned sale	Patel Kavita Non-Executive Director	1,500 -100.0% 58.43 US$87,645	1,500 -100.0%	58.43	US$87,645
2025-04-29	2025-04-29	PrS Proposed sale	Yoon Derek Director Non-Executive Director	19,470 62.02 US$1,207,529	19,470	62.02	US$1,207,529
2025-04-29	2025-04-29	PlS Planned sale	Patel Kavita Non-Executive Director	1,500 -100.0% 64.20 US$96,300	1,500 -100.0%	64.20	US$96,300
2025-04-08	2025-04-08	PlS Planned sale	Patel Kavita Non-Executive Director	1,500 -100.0% 57.50 US$86,250	1,500 -100.0%	57.50	US$86,250
2025-03-18	2025-03-18	PlS Planned sale	Patel Kavita Non-Executive Director	1,500 -100.0% 71.64 US$107,460	1,500 -100.0%	71.64	US$107,460
2025-02-26	2025-02-26	PrS Proposed sale	3.3 Elghandour Rami Officer; Director Executive Director	38,300 62.02 US$2,375,517	38,300	62.02	US$2,375,517
2025-02-26	2025-02-26	S Sale	3.3 Elghandour Rami SEE REMARKS Executive Director	10,889 -6.8% 62.69 US$682,625	10,889 -6.8%	62.69	US$682,625
2025-02-26	2025-02-26	S Sale	3.3 Elghandour Rami SEE REMARKS Executive Director	21,077 -11.6% 61.95 US$1,305,644	21,077 -11.6%	61.95	US$1,305,644
2025-02-26	2025-02-26	S Sale	3.3 Elghandour Rami SEE REMARKS Executive Director	6,334 -3.4% 61.14 US$387,248	6,334 -3.4%	61.14	US$387,248
2025-02-25	2025-02-25	PrS Proposed sale	KAVITA K PATEL Director Non-Executive Director	7,500 63.01 US$472,575	7,500	63.01	US$472,575
2025-02-25	2025-02-25	PlS Planned sale	Patel Kavita Non-Executive Director	1,500 -100.0% 63.16 US$94,740	1,500 -100.0%	63.16	US$94,740
2025-02-24	2025-02-24	PrS Proposed sale	2.3 Heery Christopher Officer Officer	10,155 63.79 US$647,773	10,155	63.79	US$647,773
2025-02-24	2025-02-24	S Sale	2.3 Heery Christopher CHIEF MEDICAL OFFICER Officer	208 -0.6% 64.88 US$13,495	208 -0.6%	64.88	US$13,495
2025-02-24	2025-02-24	S Sale	2.3 Heery Christopher CHIEF MEDICAL OFFICER Officer	5,577 -12.9% 64.26 US$358,360	5,577 -12.9%	64.26	US$358,360
2025-02-24	2025-02-24	S Sale	2.3 Heery Christopher CHIEF MEDICAL OFFICER Officer	4,370 -9.2% 63.14 US$275,918	4,370 -9.2%	63.14	US$275,918
2025-02-04	2025-02-04	PlS Planned sale	Patel Kavita Non-Executive Director	1,500 -100.0% 64.57 US$96,855	1,500 -100.0%	64.57	US$96,855
2025-01-14	2025-01-14	PlS Planned sale	Patel Kavita Non-Executive Director	300 -100.0% 67.32 US$20,195	300 -100.0%	67.32	US$20,195
2025-01-14	2025-01-14	PlS Planned sale	Patel Kavita Non-Executive Director	400 -57.1% 66.62 US$26,649	400 -57.1%	66.62	US$26,649
2025-01-14	2025-01-14	PlS Planned sale	Patel Kavita Non-Executive Director	800 -53.3% 64.95 US$51,957	800 -53.3%	64.95	US$51,957
2025-01-10	2025-01-08	S Sale	3.3 Elghandour Rami SEE REMARKS Executive Director	13,837 -10.6% 73.69 US$1,019,689	13,837 -10.6%	73.69	US$1,019,689
2025-01-10	2025-01-08	S Sale	2.8 Gilson Michelle CHIEF FINANCIAL OFFICER Officer	3,997 -29.4% 73.69 US$294,551	3,997 -29.4%	73.69	US$294,551
2025-01-10	2025-01-08	S Sale	2.3 Heery Christopher CHIEF MEDICAL OFFICER Officer	3,553 -12.4% 73.69 US$261,831	3,553 -12.4%	73.69	US$261,831
2025-01-10	2025-01-07	S Sale	3.3 Elghandour Rami SEE REMARKS Executive Director	16,474 -11.2% 75.53 US$1,244,253	16,474 -11.2%	75.53	US$1,244,253
2025-01-10	2025-01-07	S Sale	2.8 Gilson Michelle CHIEF FINANCIAL OFFICER Officer	4,760 -26.0% 75.53 US$359,515	4,760 -26.0%	75.53	US$359,515
2025-01-10	2025-01-07	PlS Planned sale	2.8 Gilson Michelle CHIEF FINANCIAL OFFICER Officer	2,327 -11.3% 77.06 US$179,320	2,327 -11.3%	77.06	US$179,320
2025-01-10	2025-01-07	PlS Planned sale	2.8 Gilson Michelle CHIEF FINANCIAL OFFICER Officer	2,251 -9.8% 76.64 US$172,522	2,251 -9.8%	76.64	US$172,522
2025-01-10	2025-01-07	PlS Planned sale	2.8 Gilson Michelle CHIEF FINANCIAL OFFICER Officer	1,546 -6.3% 75.23 US$116,311	1,546 -6.3%	75.23	US$116,311
2025-01-10	2025-01-07	PlS Planned sale	2.8 Gilson Michelle CHIEF FINANCIAL OFFICER Officer	3,128 -11.3% 74.43 US$232,807	3,128 -11.3%	74.43	US$232,807
2025-01-10	2025-01-07	S Sale	2.3 Heery Christopher CHIEF MEDICAL OFFICER Officer	4,230 -12.9% 75.53 US$319,485	4,230 -12.9%	75.53	US$319,485
2025-01-07	2025-01-07	PrS Proposed sale	2.8 MICHELLE GILSON Officer Officer	9,252 75.01 US$693,993	9,252	75.01	US$693,993
2025-01-07	2025-01-07	PrS Proposed sale	2.3 Heery Christopher Officer Officer	8,100 75.53 US$611,779	8,100	75.53	US$611,779
2025-01-07	2025-01-07	PrS Proposed sale	2.8 Gilson Michelle Officer Officer	9,100 75.53 US$687,308	9,100	75.53	US$687,308
2025-01-07	2025-01-07	PrS Proposed sale	3.3 Elghandour Rami Officer; Director Executive Director	32,000 75.53 US$2,416,906	32,000	75.53	US$2,416,906
2025-01-06	2025-01-06	S Sale	2.8 Gilson Michelle CHIEF FINANCIAL OFFICER Officer	5,102 -15.3% 77.17 US$393,705	5,102 -15.3%	77.17	US$393,705
2025-01-06	2025-01-06	S Sale	2.3 Heery Christopher CHIEF MEDICAL OFFICER Officer	3,061 -8.6% 77.17 US$236,208	3,061 -8.6%	77.17	US$236,208
2025-01-06	2025-01-06	S Sale	2.3 Heery Christopher CHIEF MEDICAL OFFICER Officer	3,061 -8.6% 77.17 US$236,208	3,061 -8.6%	77.17	US$236,208
2025-01-06	2025-01-06	S Sale	3.3 Elghandour Rami SEE REMARKS Executive Director	13,776 -8.5% 77.17 US$1,063,050	13,776 -8.5%	77.17	US$1,063,050